Antigua and Barbuda vs Saint Lucia: Hepatitis B surface antigen (HBsAg) prevalence
Antigua and Barbuda
0.2%
in 2024
Saint Lucia
0.2%
in 2024
Antigua and Barbuda rank
82nd
Saint Lucia rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Antigua and Barbuda
- Saint Lucia
How they compare
Antigua and Barbuda currently reports 0.2% against 0.2% in Saint Lucia, a difference of 0.0%.
Across all 10 years both countries report, Saint Lucia has been ahead every year.
Antigua and Barbuda ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
Head to head by decade
| Decade | Antigua and Barbuda | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Antigua and Barbuda or Saint Lucia?
- Antigua and Barbuda, at 0.2% against 0.2% in Saint Lucia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Antigua and Barbuda and Saint Lucia?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Saint Lucia?
- 10 years are reported by both, from 2015 to 2024.
- How do Antigua and Barbuda and Saint Lucia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Antigua and Barbuda ranks 82nd and Saint Lucia ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.